Conference
Phase II study of c-raf kinase antisense oligonucleotide ISIS 5132 in patients (pts) with recurrent ovarian cancer - NCICIND.116.
Authors
Oza AM; Eisenhauer E; Swenerton K; Elit L; Ghatage P; Carey M; Faught W; McIntosh L; Dorr A; Holmlund J
Volume
6
Pagination
pp. 4572S-4572S
Publisher
AMER ASSOC CANCER RESEARCH
Publication Date
November 1, 2000
Conference proceedings
CLINICAL CANCER RESEARCH
ISSN
1078-0432